Flunarizine: a possible adjuvant medication against soman poisoning?

Pierre Carpentier1, Annie Foquin, Guy Lallement

  • 1Centre de Recherches du Service de Santé des Armées, Unité de Neuropharmacologie, La Tronche Cedex, France. pierrecarpentier@crssa.net

Insights

Flunarizine (Flu) alone did not protect against soman nerve agent poisoning. However, when combined with atropine sulfate and diazepam, Flu showed a trend toward improving treatment efficacy for soman toxicity.

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Organophosphate (OP) nerve agents, such as soman, are highly toxic.
  • Soman exposure can lead to severe epileptic seizures, brain damage, and death.
  • Current therapies for soman poisoning are insufficient.

Purpose of the Study:

  • To investigate the efficacy of flunarizine (Flu) as a pretreatment against soman-induced toxicity.
  • To evaluate Flu in combination with atropine sulfate and diazepam for treating soman poisoning.

Main Methods:

  • Pretreatment with flunarizine (Flu) alone.
  • Combination therapy using Flu, atropine sulfate, and diazepam.
  • Assessment of anticonvulsant, neuroprotective, and antilethal effects against soman exposure.

Main Results:

  • Flunarizine (Flu) alone provided no significant benefit against soman-induced convulsions, neuropathology, or lethality.
  • The combination of Flu with atropine sulfate and diazepam showed a consistent trend towards improved anticonvulsant, neuroprotective, and antilethal effects.
  • Some of the observed improvements in the combination therapy group reached statistical significance.

Conclusions:

  • Flunarizine (Flu) alone is not effective in mitigating soman toxicity.
  • The combination of flunarizine with atropine sulfate and diazepam shows potential as an improved treatment regimen for soman poisoning.
  • Further research is necessary to fully ascertain the therapeutic value of flunarizine as an adjuvant in treating soman poisoning.

Related Concept Videos

Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...